The following list of Cardiology apps is from the American College of Cardiology:
ASCVD Risk Estimator Plus:
Use recent science and user feedback to help build a customized risk lowering plan by estimating and monitoring change in 10 year ASCVD risk.
AnticoagEvaluator:
Make informed decisions on antithrombotic therapy initiation for patients with AF (who do not have moderate to severe mitral stenosis or a mechanical heart valve) with the updated AnticoagEvaluator app.
ManageAnticoag:
Navigate periprocedural planning and bleed management scenarios for patients on oral anticoagulants (OAC).
CardioSmart Heart Explorer:
Use newly enhanced, high-resolution cardiac graphics and animations to help effectively review and discuss common heart problems and treatment options with patients.
Find out more at CardioSmart.org/Explorer.
CathPCI Bleeding Risk Calculator:
Assess the individualized patient risk of experiencing a bleeding event associated with a PCI procedure.
DAPT Risk Calculator:
Evaluate the continuation of DAPT therapy for patients at least 12 months post-PCI procedure, and the risk/benefit of continuing or discontinuing DAPT.
Access the Web Version >
Find out more >
Guideline Clinical App:
Access clinical guideline content, guideline recommendations, “10 Points” summaries, and tools such as risk scores, calculators and algorithms.
Find out more >
ICD/CRT Appropriate Use Criteria App:
Assess the suitability of ICD implantation and CRT with decision and documentation support.
Access the Web Version >
Find out more >
LDL-C Manager:
Reduce ASCVD risk by managing LDL-C through one continuous lipid-lowering process by linking the ASCVD Risk Estimator, Statin Intolerance app, and the brand new Lipid-Lowering Therapy tool.
Access the Web Version >
Find out more >
ManageMR:
Verify the severity and etiology of a MR with personalized referral and treatment advice for diagnosed mitral regurgitation patients.
Access the Web Version >
Find out more >
Statin Intolerance App:
Manage LDL-risk by evaluating possible intolerance to statin prescriptions.
Access the Web Version >
Find out more >
TAVR In-Hospital Mortality Risk App
Determine the predicted in-hospital mortality risk of a patient who is considering TAVR as a treatment option for AVR.
Access the Web Version >
Find out more >
TreatHF
Confirm which therapies are suggested for symptomatic heart failure patients with reduced ejection fraction (stage C HFrEF).
Access the Web Version >
Find out more >
